RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 176 filers reported holding RELAY THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 10.59 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 8,448,574 | $55,084,702 | 4.22% |
| Nextech Invest Ltd. | 3,846,409 | $25,078,587 | 4.22% |
| Finepoint Capital LP | 1,605,346 | $10,466,856 | 2.97% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $181,940,359 | 1.68% |
| MPM BioImpact LLC | 1,274,459 | $8,309,473 | 1.29% |
| HARBOURVEST PARTNERS LLC | 296,402 | $1,932,541 | 1.03% |
| Prosight Management, LP | 385,000 | $2,510,200 | 0.75% |
| Logos Global Management LP | 1,300,000 | $8,476,000 | 0.69% |
| Bellevue Group AG | 6,377,115 | $41,578,790 | 0.68% |
| Boxer Capital, LLC | 1,819,132 | $11,860,741 | 0.62% |
| BRAIDWELL LP | 3,006,799 | $19,604,329 | 0.62% |
| Alphabet Inc. | 1,568,753 | $10,228,270 | 0.52% |
| Integral Health Asset Management, LLC | 750,000 | $4,890,000 | 0.46% |
| Fernwood Investment Management, LLC | 185,763 | $1,211,175 | 0.38% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $207,382 | 0.22% |
| Rhenman & Partners Asset Management AB | 230,000 | $1,499,600 | 0.14% |
| PDT Partners, LLC | 226,632 | $1,477,641 | 0.14% |
| TrueMark Investments, LLC | 54,445 | $354,981 | 0.12% |
| Intellectus Partners, LLC | 67,675 | $441,241 | 0.12% |
| ALGERT GLOBAL LLC | 476,888 | $3,109 | 0.10% |
External links
This page lists RELAY THERAPEUTICS INC's shareholders in Q2 2024. To view RELAY THERAPEUTICS INC's shareholder history, click here.